Zakia Alavi

Zakia Alavi

Affiliate

Assistant Professor
Department of Pediatrics and Human Development Medical Education

Email

Bio

 

Zakia Alavi MD is a child and adult psychiatrist, a Diplomat of American Board of Psychiatry and Neurology. Dr. Alavi obtained her medical education Dow Medical University, Pakistan. She completed her residency in psychiatry, followed by a fellowship in child psychiatry, from Wayne State University. Dr. Alavi has worked in both clinical and academic settings, since 1999. Currently, Dr. Alavi is engaged in providing psychiatric services to underprivileged children in Jackson Michigan. Dr. Alavi is the chief medical officer for Midstate Health Network, which is a Medicaid Managed Care Organization, providing behavioral health services for 21 counties in Michigan. In 2009, Dr. Alavi was appointed as the Medical Director for Children Services- Department of Health and Human Services. Here, Dr. Alavi developed and implemented health coordination for all foster children in Michigan. In 2012, Dr. Alavi, being invited by the Program in Public, College of Human Medicine, Michigan State University, to develop and teach a course on Psychiatry and Public Health, joined the academic faculty, which has since, become her academic home.

Dr. Zakia Alavi is currently serving as an Assistant Professor in the Department of Pediatrics and Department of Medical Education. Her academic responsibilities include teaching medical students integration between basic and clinical sciences. For the Dept. of Pediatrics, Dr. Alavi is involved in developing a telemedicine pilot, which will provide psychiatric and neurodevelopmental consultation to pediatricians in the Upper Peninsula of Michigan. Dr Alavi is also a co-moderator for the International Collaborative Office Rounds 2(ICOR2), an Inter-professional monthly meeting of US and international clinicians, that includes Primary Care Pediatricians, Developmental Pediatricians and Child psychiatrists. Dr. Alavi has published several peer reviewed articles; her primary interest in polypharmacy in children and geriatric population.